The Clinical Observation Of Tanghankang In Treatment Of Diabetic Sweating Dysfunction(Qi Deficiency Is Not Solid,Yin Asthenia And Internal Heat)

Objective: To observe clinical efficacy of the Tanghankang on diabetic sweating dysfunction hyperhidrosis(qi deficiency is not solid, yin asthenia and internal heat). In order to further optimize established the formula of Tanghankang.Methods: 60 patients were randomly divided into two groups by using SPSS17.0software based on the order numbers of admission. The 30 patients in treatment group were given basic treatment and Jiaguan capsule plus Tanghankang, while the 30 cases in control group were given basic treatment and Jiaguan capsule. Treatment observation period for 2weeks. Observed indexes include TCM syndrome score, FPG, 2h PPG, TC, TG, HDL-C,LDL-C, Apo B and hs-CRP. After the experiment, to observe the improvement of clinical symptoms and related indexes in two groups. The data was analyzed by using SPSS17.0software.Results:1. The comparison of TCM syndrome, the total efficacy in the treatment group was86.67 %, while the control group was 56.67 %. The treatment group was better than the control group(P<0.05). The comparison of TCM syndrome integral, the symptoms and signs of two groups were improved. The difference was statistically significant(P<0.05). The TCM syndrome integral of the treatment group was reduced obviouly. The treatment group was better than the control group(P<0.05).2. The FPG and 2h PPG of two groups after treatment comparison were decreased. The difference of after treatment compared with before treatment was statistically significant(P<0.05). After treatment comparison in two groups, the treatment group was better than control group, difference was statistically significant(P<0.05).3. In improving the disorder of lipid metabolism, the TC, TG, HDL-C, LDL-C and Apo B of two groups after treatment were improved. The difference of after treatment compared with the previous treatment was statistically significant(P<0.05). But in improved the disorder of lipid metabolism, the treatment group was better than the control group. The difference was statistically significant(P<0.05).4. High sensitive C-reactive protein of the two groups after treatment was reducedslightly, but the comparison of within group and between group was showed no significant difference(P>0.05).5. The comparison of comprehensive curative effect, the total effective rate of treatment group was 83.33%, while the control group was 50%. The treatment group was better than the control group(P<0.05).6. Neither the treatment group nor the control group was showed any adverse reactions.Conclusions:1. Tanghankang can improve the clinical symptoms of patients with diabetic sweating dysfunction and improve the quality of patients life.2. Tanghankang has a good regulating effect on patients’ blood sugar and blood lipid metabolism disorder.3. No adverse reactions were found in the clinical application of Tanghankang. The clinical application safely.